Clincosm LogoSign in Get a demo

Colo-rectal Cancer

Showing 1 - 25 of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric/Colorectal Cancers

Not yet recruiting
  • Gastric Cancer
  • Colo-rectal Cancer
  • quantitative Real-time PCR
  • (no location specified)
Nov 27, 2023

Serum autotaxin Level in Colorectal Cancer

Completed
  • Colo-rectal Cancer
  • Serum autotaxın levels
  • Ankara, Turkey
    Dışkapı Yıldırım Beyazıt training and research hospital
Oct 14, 2023

Spectral CT-scan in Metastatic Colorectal Cancer:Prospective

Recruiting
  • Colo-rectal Cancer
  • CT Images
  • Saint-Étienne, France
    CHU Saint-Etienne
Aug 29, 2023

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)

Recruiting
  • Colo-rectal Cancer
  • adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
  • Beijing, China/Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medici
Aug 4, 2023

Validation of the Global Polypectomy Assessment Tool (GPAT)

Enrolling by invitation
  • Colorectal Adenoma
  • +2 more
    • Ghent, Gent, Belgium
      uz Gent
    May 17, 2023

    Artificial Intelligence in Adenoma Detection for Colonoscopy

    Not yet recruiting
    • Colonic Polyp
    • +2 more
    • GI Genius (GIG)
    • (no location specified)
    May 11, 2023

    Colo-rectal Cancer Trial in Ravenna (Prehabilitation course)

    Recruiting
    • Colo-rectal Cancer
    • Prehabilitation course
    • Ravenna, RA, Italy
      AUSL della Romagna
    May 5, 2023

    Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])

    Completed
    • Gastric Cancer
    • +2 more
    • Ramucirumab Injection
    • Ramucirumab Injection [Cyramza]
    • Changchun, Jilin, China
      Affiliated Hospital of Changchun University of Traditional Chine
    Mar 24, 2023

    Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

    Not yet recruiting
    • Solid Tumor
    • +4 more
    • (no location specified)
    Feb 21, 2023

    Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

    Not yet recruiting
    • Cancer
    • +16 more
    • KVA12123 - Dose Escalation
    • +3 more
    • (no location specified)
    Feb 2, 2023

    Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

    Active, not recruiting
    • Colo-rectal Cancer
    • Metastatic Cancer
    • Besançon, France
    • +2 more
    Jan 24, 2023

    Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

    Active, not recruiting
    • Advanced Cancer
    • +16 more
    • Scottsdale, Arizona
    • +3 more
    Dec 22, 2022

    Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

    Recruiting
    • Solid Tumor
    • +3 more
    • Denver, Colorado
    • +2 more
    Dec 19, 2022

    Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • +11 more
    • Tucson, Arizona
    • +11 more
    Dec 2, 2022

    Colo-rectal Cancer, Neuropathy;Peripheral, Mucositis Trial in Tanta (Pentoxifylline, Placebo, FOLFOX-6 regimen)

    Enrolling by invitation
    • Colo-rectal Cancer
    • +2 more
    • Tanta, Gharbyia, Egypt
      Tanta University
    Oct 18, 2022

    Peritoneum Cancer, Peritoneal Carcinomatosis, Peritoneal Metastases Trial in Odense (PIPAC)

    Recruiting
    • Peritoneum Cancer
    • +3 more
    • Odense, Denmark
      Odense PIPAC Center, Department of Surgery, Odense University Ho
    Oct 5, 2022

    Colo-rectal Cancer, Colonic Tumors Trial in Coimbra (PEG split-dose and simethicone)

    Completed
    • Colo-rectal Cancer
    • Colonic Neoplasms
    • PEG split-dose and simethicone
    • Coimbra, Portugal
      Portuguese Oncology Institute - Coimbra
    Oct 3, 2022

    Colo-rectal Cancer Trial in Buffalo (Problem solving Skills Training)

    Completed
    Has Results
    • Colo-rectal Cancer
    • Problem solving Skills Training
    • Buffalo, New York
      Roswell Park Cancer Institute
    Sep 9, 2022

    Colo-rectal Cancer, Polyp of Colon, Adenomatous Polyp of Colon Trial in Palo Alto (Use of EverLift, Without use of EverLift)

    Completed
    Has Results
    • Colo-rectal Cancer
    • +2 more
    • Use of EverLift
    • Without use of EverLift
    • Palo Alto, California
      Veterans Affairs Palo Alto Health Care System
    Aug 12, 2022

    Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer

    Recruiting
    • Colo-rectal Cancer
    • serum HOTTIP ,EIF4EBP1 and serum SNP HOTTIP rs1859168
    • Assiut, Egypt
      Assiut University
    Aug 18, 2022

    Patient Empowerment, Low Anterior Resection Syndrome, Colo-rectal Cancer Trial in Canada (Interactive online informational and

    Recruiting
    • Patient Empowerment
    • +6 more
    • Interactive online informational and peer support app
    • Vancouver, British Columbia, Canada
    • +4 more
    Aug 17, 2022

    Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

    Recruiting
    • Advanced Solid Tumor
    • +18 more
    • PT199
    • Anti-PD-1 monoclonal antibody
    • Huntersville, North Carolina
    • +2 more
    Aug 10, 2022

    Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)

    Not yet recruiting
    • Colorectal Cancer
    • +3 more
    • (no location specified)
    Jul 28, 2022

    HLA Typing and Tumor Neoantigen Identification forPhase I/II

    Recruiting
    • Ovarian Cancer
    • +5 more
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 27, 2022